why Asensus Surgical Inc. [ASXC] is a Good Choice for Investors After New Price Target of $4.00

Asensus Surgical Inc. [AMEX: ASXC] price plunged by -3.14 percent to reach at -$0.07. The company report on July 26, 2021 that Asensus Surgical Announces the Appointment of Two New Board Members.

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced the expansion of its Board of Directors, appointing two new board members, Elizabeth Kwo, MD and Kevin Hobert, effective immediately.

“We are delighted to welcome two accomplished industry veterans to our Board of Directors, each of whom bring highly relevant and unique skills to the organization that complement our current leadership team in an impactful way,” said Paul LaViolette, Chairman of the Board of Asensus Surgical. “Liz has a tremendous track record of bringing innovative healthcare technology to the market, and has a highly specialized expertise in leveraging predictive analytics and big data to improve patient outcomes through digital solutions, making her a perfect fit as we seek to revolutionize digital surgery. Kevin has extensive experience leading global technology businesses, and importantly was an integral part in the early development of innovative digital imaging technology that leveraged AI and proprietary algorithms. We look forward to tapping into their combined talents as we continue to work to drive the widespread commercial adoption of Senhance® Surgical System on a global scale.”.

A sum of 7522444 shares traded at recent session while its average daily volume was at 10.31M shares. Asensus Surgical Inc. shares reached a high of $2.26 and dropped to a low of $2.09 until finishing in the latest session at $2.16.

The one-year ASXC stock forecast points to a potential upside of 46.0. The average equity rating for ASXC stock is currently 2.50, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Asensus Surgical Inc. [ASXC]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ASXC shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ASXC stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

H.C. Wainwright have made an estimate for Asensus Surgical Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 26, 2021.

The Average True Range (ATR) for Asensus Surgical Inc. is set at 0.26, with the Price to Sales ratio for ASXC stock in the period of the last 12 months amounting to 115.77. The Price to Book ratio for the last quarter was 2.16.

ASXC Stock Performance Analysis:

Asensus Surgical Inc. [ASXC] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.94. With this latest performance, ASXC shares dropped by -34.55% in over the last four-week period, additionally sinking by -40.17% over the last 6 months – not to mention a rise of 470.07% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASXC stock in for the last two-week period is set at 36.28, with the RSI for the last a single of trading hit 31.58, and the three-weeks RSI is set at 40.22 for Asensus Surgical Inc. [ASXC]. The present Moving Average for the last 50 days of trading for this stock 2.74, while it was recorded at 2.40 for the last single week of trading, and 2.26 for the last 200 days.

Insight into Asensus Surgical Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Asensus Surgical Inc. [ASXC] shares currently have an operating margin of -1783.12 and a Gross Margin at -402.90. Asensus Surgical Inc.’s Net Margin is presently recorded at -1868.09.

Return on Total Capital for ASXC is now -91.50, given the latest momentum, and Return on Invested Capital for the company is -98.26. Return on Equity for this stock declined to -101.30, with Return on Assets sitting at -72.71. When it comes to the capital structure of this company, Asensus Surgical Inc. [ASXC] has a Total Debt to Total Equity ratio set at 6.71. Additionally, ASXC Total Debt to Total Capital is recorded at 6.28, with Total Debt to Total Assets ending up at 5.00. Long-Term Debt to Equity for the company is recorded at 3.60, with the Long-Term Debt to Total Capital now at 3.37.

Reflecting on the efficiency of the workforce at the company, Asensus Surgical Inc. [ASXC] managed to generate an average of -$429,797 per employee. Receivables Turnover for the company is 0.87 with a Total Asset Turnover recorded at a value of 0.04.Asensus Surgical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 18.00 and a Current Ratio set at 19.20.

Asensus Surgical Inc. [ASXC] Insider Position Details

There are presently around $75 million, or 19.50% of ASXC stock, in the hands of institutional investors. The top three institutional holders of ASXC stocks are: INVESCO LTD. with ownership of 7,109,464, which is approximately 6598.195% of the company’s market cap and around 0.50% of the total institutional ownership; VANGUARD GROUP INC, holding 6,132,801 shares of the stock with an approximate value of $13.25 million in ASXC stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $5.83 million in ASXC stock with ownership of nearly 89.233% of the company’s market capitalization.

>> 7 Top Picks for the Post-Pandemic Economy <<

Positions in Asensus Surgical Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 72 institutional holders increased their position in Asensus Surgical Inc. [AMEX:ASXC] by around 27,447,140 shares. Additionally, 19 investors decreased positions by around 1,750,487 shares, while 20 investors held positions by with 5,637,047 shares. The mentioned changes placed institutional holdings at 34,834,674 shares, according to the latest SEC report filing. ASXC stock had 45 new institutional investments in for a total of 9,762,685 shares, while 13 institutional investors sold positions of 1,667,549 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam